Stay informed with the latest litigation news. Explore now

Biocon competitive analysis

Latest publications and patents of Biocon New

Explore the latest publications and patents granted to Biocon, showcasing their recent innovations and technological advancements.

Last updated on: Sep 7, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biocon

Jun 6, 2018Methods For Reducing Accumulation Of Lactate During Culturing And Method For Producing PolypeptideRevoked
May 30, 2018Targeted/Immunomodulatory Fusion Proteins And Methods For Making SameOpposition Rejected
Jan 17, 2018A Process For Purification Of PneumocandinNo Opposition Filed Within Time Limit

Explore patent oppositions filed by Biocon against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 11, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 AntibodyJANSSEN BIOTECHApr 8, 2024
A BiopesticideCITRUS RESEARCHSep 10, 2020

Explore Biocon's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jun 6, 2018Methods For Reducing Accumulation Of Lactate During Culturing And Method For Producing Polypeptide1
May 30, 2018Targeted/Immunomodulatory Fusion Proteins And Methods For Making Same1

Latest PTAB cases involving Biocon New

Discover the latest PTAB cases involving Biocon, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Biocon

IPR2024-00298Dec 18, 2023BIOCON BIOLOGICSREGENERON PHARMACEUTICALSTerminated-Adverse Judgment
IPR2023-01444Nov 22, 2023BIOCON BIOLOGICSJANSSEN BIOTECHTerminated-Settled
IPR2024-00201Nov 20, 2023BIOCON BIOLOGICSREGENERON PHARMACEUTICALSTerminated-Adverse Judgment
IPR2020-01263Aug 7, 2020BIOCON PHARMANOVARTIS PHARMACEUTICALSInstitution Denied
IPR2016-00175Nov 10, 2015THE JOHN HOPKINS UNIVERSITYBIOCONInstitution Denied

Top competitors of Biocon

Top competitors of Biocon based on patent oppositions.